CACI International
CACI International's revenue rose 10.9% to $9.6 billion in fiscal 2026. Its operating margin was 9.6%, up from 8.9% a year earlier. Free cash flow was $780 million, up 62.0%. It paid out $17 million in dividends and buybacks, 2% of free cash flow. The diluted share count fell 1.0%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2017 to 2026, earnings per share grew 15.6% a year and net income 14.1% a year, as buybacks cut the share count by 12%.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value CACI International yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from CACI International's 10-K (or, for net cash and shares, its latest 10-Q) and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from CACI International's fiscal 2026 free cash flow of $780M, net cash of −$4.7B at June 30, 2026 and 22 million diluted shares, from its filings. The scenarios are fitted to CACI International: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 12.6% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Diversified Support Services); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $665.00
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from CACI International's earnings per share of $24.36 (over the last four quarters). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 26.7×, the middle of CACI International's own P/E today, its peers' median and its sector's median (the Industrials median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $665.00
- Value at this multiple, against the last close
- —
- CACI International's P/E at the last close
- 27.3×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| CintasCTAS | $225.93 | $5.07 | 44.6× |
| CACI InternationalCACI | $665.00 | $24.36 | 27.3× |
| Science Applications IntlSAIC | $148.51 | $8.56 | 17.3× |
| LeidosLDOS | $139.86 | $10.71 | 13.1× |
| KBRKBR | $40.02 | $3.33 | 12.0× |
Balance sheet
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 115 | 116 | 134 | 106 | 192 |
| Debt incl. finance leases | 1,733 | 1,696 | 1,543 | 2,918 | 4,902 |
| Net debt (negative means net cash) | 1,618 | 1,581 | 1,409 | 2,812 | 4,710 |
| Net debt to EBITDA | 2.6x | 2.2x | 2.0x | 3.4x | 4.7x |
| Debt to equity | 0.6x | 0.5x | 0.4x | 0.8x | 1.1x |
| Interest coverage | 11.9x | 6.8x | 6.2x | 4.8x | 4.3x |
| Current ratio | 1.2x | 1.2x | 1.3x | 1.5x | 1.5x |
| Quick ratio | 1.1x | 1.1x | 1.2x | 1.4x | 1.4x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought CACI International shares on the open market, and 4 insiders sold $3.3 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 16, 2026 | Susan M. GordonDirector | Sold | 264 | $500.38 | $132,100 | Form 4 |
| Mar 11, 2026 | Debora A PlunkettDirector | Sold | 220 | $603.30 | $132,726 | Form 4 |
| Feb 10, 2026 | Koegel J William JREVP, General Counsel | Sold | 2,000 | $615.06 | $1.2 million | Form 4 |
| Dec 10, 2025 | William L JewsDirector | Sold | 3,000 | $585.82 | $1.8 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Pass | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Pass | Pass | Pass |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Pass | Pass | Fail |
| F-score | 8 of 8 | 7 of 8 | 5 of 8 |
| Accruals ratio | −1.2% | −0.6% | −3.4% |
Compare
Put CACI International side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| CACI International | FY26 | 10.9% | 9.6% | 8.2% | 8.8% | 4.7x | 5 | |
| Cintas | FY26 | 8.9% | 23.1% | 16.7% | 31.7% | 0.4x | 8 | Compare |
| KBR | FY25 | 1.0% | 10.0% | 6.6% | 15.8% | 2.2x | 7 | Compare |
| Science Applications Intl | FY26 | −2.9% | 7.2% | 8.0% | 12.8% | 4.2x | 7 | Compare |
| Leidos | FY25 | 3.1% | 12.3% | 9.5% | 19.2% | 1.5x | 9 | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 4,355 | 4,468 | 4,986 | 5,720 | 6,044 | 6,203 | 6,702 | 7,660 | 8,628 | 9,568 |
| Revenue growth | 16.3% | 2.6% | 11.6% | 14.7% | 5.7% | 2.6% | 8.1% | 14.3% | 12.6% | 10.9% |
| Gross profit | 297 | 341 | 378 | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 297 | 341 | 378 | 458 | 540 | 496 | 568 | 650 | 764 | 920 |
| Net income | 164 | 301 | 266 | 322 | 457 | 367 | 385 | 420 | 500 | 536 |
| Diluted EPS (US$) | 6.53 | 11.93 | 10.46 | 12.61 | 18.30 | 15.49 | 16.43 | 18.60 | 22.32 | 24.16 |
| Diluted shares (millions) | 25 | 25 | 25 | 26 | 25 | 24 | 23 | 23 | 22 | 22 |
| Cash flow | ||||||||||
| Cash from operations | 281 | 322 | 555 | 519 | 592 | 746 | 388 | 497 | 547 | 887 |
| Capital expenditure | 43 | 42 | 48 | 72 | 73 | 75 | 64 | 64 | 66 | 107 |
| Free cash flow | 238 | 280 | 507 | 446 | 519 | 671 | 324 | 434 | 481 | 780 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 4 | 5 | 6 | 8 | 509 | 10 | 273 | 162 | 169 | 17 |
| Acquisitions | 7 | 77 | 1,083 | 106 | 356 | 616 | 14 | 90 | 1,696 | 2,636 |
| Stock-based compensation | 22 | 24 | 25 | 29 | 30 | 32 | 40 | 54 | 60 | 80 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 66 | 66 | 72 | 107 | 88 | 115 | 116 | 134 | 106 | 192 |
| Debt incl. finance leases | 1,232 | 1,062 | 1,665 | 1,404 | 1,736 | 1,733 | 1,696 | 1,543 | 2,918 | 4,902 |
| Total assets | 3,911 | 4,034 | 5,087 | 5,542 | 6,172 | 6,629 | 6,601 | 6,796 | 8,648 | 11,820 |
| Total liabilities | 2,117 | 1,927 | 2,715 | 2,881 | 3,507 | 3,576 | 3,376 | 3,278 | 4,754 | 7,357 |
| Shareholders' equity | 1,794 | 2,107 | 2,371 | 2,661 | 2,665 | 3,053 | 3,224 | 3,518 | 3,894 | 4,463 |
| Margins and ratios | ||||||||||
| Gross margin | 6.8% | 7.6% | 7.6% | — | — | — | — | — | — | — |
| Operating margin | 6.8% | 7.6% | 7.6% | 8.0% | 8.9% | 8.0% | 8.5% | 8.5% | 8.9% | 9.6% |
| Net margin | 3.8% | 6.7% | 5.3% | 5.6% | 7.6% | 5.9% | 5.7% | 5.5% | 5.8% | 5.6% |
| Free cash flow margin | 5.5% | 6.3% | 10.2% | 7.8% | 8.6% | 10.8% | 4.8% | 5.7% | 5.6% | 8.2% |
| Return on capital | 6.5% | 11.2% | 8.7% | 9.2% | 11.9% | 8.9% | 9.5% | 10.3% | 10.8% | 8.8% |
| Return on equity | 9.6% | 15.4% | 11.9% | 12.8% | 17.2% | 12.8% | 12.3% | 12.5% | 13.5% | 12.8% |
| Return on assets | 4.1% | 7.6% | 5.8% | 6.0% | 7.8% | 5.7% | 5.8% | 6.3% | 6.5% | 5.2% |
| Net debt to EBITDA | 3.2x | 2.4x | 3.4x | 2.3x | 2.5x | 2.6x | 2.2x | 2.0x | 3.4x | 4.7x |